Lasa Supergenerics Ltd
Fri 19/12/2025,15:40:25 | NSE : LASA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 9.37
Previous Close
₹ 9.37
Volume
57492
Mkt Cap ( Rs. Cr)
₹45.69
High
₹ 9.48
Low
₹ 8.51
52 Week High
₹ 31.40
52 Week Low
₹ 8.16
Book Value Per Share
₹ 16.71
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Lasa Supergenerics Ltd
Your Vote -
Buy
26.92%
Hold
3.85%
Sell
69.23%
26.92%
26 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Lasa Supergenerics Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Lasa Supergenerics - Appointment of Company Secretary and Compliance Officer
-
Lasa Supergenerics - Cessation
-
Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Cessation
-
Lasa Supergenerics posts Q2 net loss of Rs 6.25 cr
-
Lasa Supergenerics - Updates
-
Lasa Supergenerics - Related Party Trasnaction As 30.09.2025
-
Lasa Supergenerics - Outcome of Board Meeting
-
Lasa Supergenerics - Integrated Filing- Financial
-
Lasa Supergenerics - Integrated Filing September 30 ,2025
-
Lasa Supergenerics - Updates
-
Lasa Supergenerics - Results As On 30 Th Septemer 2025
-
Lasa Supergenerics - Outcome of Board Meeting
-
Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended 30 September, 2025
-
Lasa Supergenerics - Update on board meeting
-
Lasa Supergenerics - Board Meeting Intimation for The Quarter And Half Year Ended September 30, 2025
-
Lasa Supergenerics - Structural Digital Database
-
Lasa Supergenerics has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Lasa Supergenerics - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Lasa Supergenerics - Shareholders meeting
-
Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Lasa Supergenerics - Shareholders meeting
-
Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Lasa Supergenerics - Trading Window
-
Lasa Supergenerics - General Updates
-
Lasa Supergenerics - Annoucement Under Reg 30 Updates - Revised Disclosure Resignation Of Company Secretary
-
Lasa Supergenerics to start trial runs from Nov 25
Key fundamentals
Evaluate the intrinsic value of Lasa Supergenerics Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 83.7132 | 96.6762 | 118.2859 | 148.6341 | 158.9171 |
| Liabilities | 83.7132 | 96.6762 | 118.2859 | 148.6341 | 158.9171 |
| Equity | 50.1012 | 50.1012 | 50.1012 | 40.6727 | 40.6727 |
| Gross Profit | 6.2659 | 2.1658 | -6.5935 | 15.6327 | 47.221 |
| Net Profit | -14.7573 | -21.7306 | -38.6207 | -5.3672 | 22.7777 |
| Cash From Operating Activities | -2.8237 | 2.1387 | -17.3004 | 10.4898 | 41.3103 |
| NPM(%) | -10.35 | -20.82 | -29.8 | -3.91 | 11.25 |
| Revenue | 142.4481 | 104.335 | 129.5678 | 137.1267 | 202.3795 |
| Expenses | 136.1822 | 102.1692 | 136.1613 | 121.494 | 155.1585 |
| ROE(%) | -17.62 | -25.95 | -46.13 | -6.41 | 27.2 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 16 Sep 2022 | 0.25 | 2.5 | 0 | 62.35 |
| 15 Sep 2021 | 0.25 | 2.5 | 0 | 73.6 |
Peers
Other companies within the same industry or sector that are comparable to Lasa Supergenerics Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Sharda Cropchem Ltd | 883.85 | -0.32 | 17.65 | 82.64 | 337.37 | 1.02 |
| Amines and Plasticizers Ltd | 202.06 | -2.44 | 30.75 | 50.40 | 372.61 | 0.25 |
| Indogulf Cropsciences Ltd | 80.30 | 1.88 | 9.58 | 44.69 | 49.78 | 0.00 |
| Grauer and Weil (India) Ltd | 115.60 | 0.00 | 34.71 | 415.33 | 346.70 | 0.43 |
Company Info
Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.
Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.
Read More
Parent Organisation
Lasa Supergenerics Ltd.
Founded
11/11/2016
Managing Director
Dr.Omkar Pravin Herlekar
NSE Symbol
LASAEQ
FAQ
The current price of Lasa Supergenerics Ltd is ₹ 9.12.
The 52-week high for Lasa Supergenerics Ltd is ₹ 9.48 and the 52-week low is ₹ 8.51.
The market capitalization of Lasa Supergenerics Ltd is currently ₹ 45.69. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Lasa Supergenerics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Lasa Supergenerics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Lasa Supergenerics Ltd shares.
The CEO of Lasa Supergenerics Ltd is Dr.Omkar Pravin Herlekar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
